Bioactive Materials · 2023 · 41 citations · 50 references
MedicineOncologySurgeryChemotherapyDrug DeliveryImmunotherapyBladder CancerCancer Drug DeliveryCancer ImmunotherapyGelsHydrogel BiomaterialsHydrogelsCombination TherapyDrug Delivery GelsDrug Delivery HydrogelsHydrogel Drug Delivery SystemsIntravesical ChemotherapySol-gel TransitionThermoresponsive GelsThermoresponsive Hydrogels
Surgical resection remains the prefer option for bladder cancer treatment. However, the effectiveness of surgery is usually limited for the high recurrence rate and poor prognosis. Consequently, intravesical chemotherapy synergize with immunotherapy in situ is an attractive way to improve therapeutic effect. Herein, a combined strategy based on thermo-sensitive PLEL hydrogel drug delivery system was developed. GEM loaded PLEL hydrogel was intravesical instilled to kill tumor cells directly, then PLEL hydrogel incorporated with CpG was injected into both groins subcutaneously to promote immune responses synergize with GEM. The results demonstrated that drug loaded PLEL hydrogel had a sol-gel phase transition behavior in response to physiological temperature and presented sustained drug release, and the PLEL-assisted combination therapy could have better tumor suppression effect and stronger immunostimulating effect in vivo. Hence, this combined treatment with PLEL hydrogel system has great potential and suggests a clinically-relevant and valuable option for bladder cancer.
50
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
J. Alfred Witjes, Thierry Lebrét, Éva Compérat et al. · European Urology · 2016 · 1.5K citations
Elizabeth Poplin, Yang Feng, Jordan Berlin et al. · Journal of Clinical Oncology · 2009 · 432 citations · Full text
Medicine, Oncology, Pharmacology +14